Logo image of LGMK

LOGICMARK INC (LGMK) Stock Fundamental Analysis

NASDAQ:LGMK - Nasdaq - US67091J6029 - Common Stock - Currency: USD

0.0094  0 (-3.09%)

After market: 0.0098 +0 (+4.26%)

Fundamental Rating

2

Taking everything into account, LGMK scores 2 out of 10 in our fundamental rating. LGMK was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While LGMK seems to be doing ok healthwise, there are quite some concerns on its profitability. LGMK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LGMK had negative earnings in the past year.
In the past year LGMK has reported a negative cash flow from operations.
In the past 5 years LGMK always reported negative net income.
LGMK had a negative operating cash flow in each of the past 5 years.
LGMK Yearly Net Income VS EBIT VS OCF VS FCFLGMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

LGMK has a worse Return On Assets (-65.42%) than 73.68% of its industry peers.
With a Return On Equity value of -76.31%, LGMK is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -65.42%
ROE -76.31%
ROIC N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
LGMK Yearly ROA, ROE, ROICLGMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

With a decent Gross Margin value of 66.81%, LGMK is doing good in the industry, outperforming 70.53% of the companies in the same industry.
In the last couple of years the Gross Margin of LGMK has declined.
The Profit Margin and Operating Margin are not available for LGMK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
LGMK Yearly Profit, Operating, Gross MarginsLGMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

6

2. Health

2.1 Basic Checks

LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LGMK has been increased compared to 1 year ago.
Compared to 5 years ago, LGMK has more shares outstanding
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LGMK Yearly Shares OutstandingLGMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
LGMK Yearly Total Debt VS Total AssetsLGMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -11.38, we must say that LGMK is in the distress zone and has some risk of bankruptcy.
LGMK's Altman-Z score of -11.38 is on the low side compared to the rest of the industry. LGMK is outperformed by 77.89% of its industry peers.
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.38
ROIC/WACCN/A
WACC8.98%
LGMK Yearly LT Debt VS Equity VS FCFLGMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

LGMK has a Current Ratio of 2.63. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.63, LGMK perfoms like the industry average, outperforming 51.05% of the companies in the same industry.
A Quick Ratio of 2.11 indicates that LGMK has no problem at all paying its short term obligations.
LGMK has a Quick ratio (2.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.11
LGMK Yearly Current Assets VS Current LiabilitesLGMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for LGMK have decreased strongly by -393.42% in the last year.
Looking at the last year, LGMK shows a decrease in Revenue. The Revenue has decreased by -0.28% in the last year.
The Revenue for LGMK have been decreasing by -10.39% on average. This is quite bad
EPS 1Y (TTM)-393.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-669.36%
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-7.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGMK Yearly Revenue VS EstimatesLGMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
LGMK Yearly EPS VS EstimatesLGMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2023 2024 -5K -10K -15K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LGMK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGMK Price Earnings VS Forward Price EarningsLGMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGMK Per share dataLGMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LGMK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOGICMARK INC

NASDAQ:LGMK (4/17/2025, 8:00:02 PM)

After market: 0.0098 +0 (+4.26%)

0.0094

0 (-3.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-31 2025-03-31/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners14.43%
Inst Owner Change0%
Ins Owners8.28%
Ins Owner Change72.7%
Market Cap569.55K
Analysts43.33
Price Target4.08 (43304.26%)
Short Float %3.76%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.13
Dividend Growth(5Y)N/A
DP-3.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-475.72%
Min EPS beat(2)-1005.85%
Max EPS beat(2)54.4%
EPS beat(4)3
Avg EPS beat(4)-233.53%
Min EPS beat(4)-1005.85%
Max EPS beat(4)54.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.78%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)8.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)8.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-63.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.16
BVpS0.2
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.42%
ROE -76.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.81%
FCFM N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.59%
Cap/Sales 0.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.11
Altman-Z -11.38
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)13.92%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-393.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-669.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-7.25%
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.41%
OCF growth 3YN/A
OCF growth 5YN/A